GH Research PLC
GHRS- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001855129
No open-market purchases or sales by GH Research PLC insiders were filed in the last 90 days; 63 institutions reported holding it in 13F filings for Q2 2026, worth $1.38B in total; no superinvestor holds it.
Q3 2025 vs. Q2 2025
How the institutions holding GH Research PLC changed between Q2 2025 and Q3 2025.
All holders in Q3 2025All holders in Q2 2025
| Measure | Q2 2025 | Q3 2025 | Change |
|---|---|---|---|
| Holders | 38 | 47 | +9 |
| Shares | 43.6M | 44.5M | +979.2K (+2.2%) |
| Value | $530.9M | $618.1M | +$87.2M (+16.4%) |
New holders (14)
Institutions that held GH Research PLC at the end of Q3 2025 but not at the end of Q2 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Marshall Wace, LLP | 169,500 | $2.42M | 0.00% |
| CenterBook Partners LP | 166,153 | $2.38M | 0.12% |
| Citadel Advisors LLC | 94,402 | $1.35M | 0.00% |
| Point72 Asset Management, L.P. | 76,958 | $1.10M | 0.00% |
| Squarepoint Ops LLC | 36,103 | $516.3K | 0.00% |
| Tang Capital Management LLC | 24,030 | $343.6K | 0.01% |
| Jane Street Group, LLC | 23,004 | $329.0K | 0.00% |
| Cubist Systematic Strategies, LLC | 22,732 | $325.1K | 0.00% |
| Man Group plc | 22,060 | $315.5K | 0.00% |
| Goldman Sachs Group Inc | 11,075 | $158.4K | 0.00% |
| State Street Corp | 10,992 | $157.2K | 0.00% |
| Barclays PLC | 1,296 | $18.5K | 0.00% |
| Farther Finance Advisors, LLC | 200 | $2.86K | 0.00% |
| Citigroup Inc | 31 | $443 | 0.00% |
Sold out (5)
Institutions that held GH Research PLC at the end of Q2 2025 and filed for Q3 2025 without it.
| Institution | Shares, Q2 2025 | Value, Q2 2025 |
|---|---|---|
| Toronto Dominion Bank | 1,967,293 | $24.0M |
| Palumbo Wealth Management LLC | 21,651 | $263.9K |
| Quadrature Capital Ltd | 20,108 | $245.5K |
| PEAK6 LLC | 20,000 | $243.8K |
| Loring Wolcott & Coolidge Fiduciary Advisors LLP | 2,000 | $24.4K |